1 - 25 of 17
Number of results to display per page
TitleCreatorDate
1 A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone for Neuroprotection in Acute Optic NeuritisJeffrey L. Bennett; Nathan C. Grove; Ruth K. Johnson; Christopher Mizenko; Joan C. DuPont; Brandie D. Wagner; Anne M. Lynch; Teresa C. Frohman; Kenneth S. Shindler; Elliot M. Frohman2023-09
2 Sharp Edge Eye Syndrome: A Case Report and Survey of Self-Identified IndividualsMerrick S. Reynolds; Bradley J. Katz; Kathleen B. Digre; Ben J. Brintz; Lenora M. Olson; Judith E. A. Warner2022-12
3 The Impact of Leber Hereditary Optic Neuropathy on the Quality of Life of Patients and Their Relatives: A Qualitative StudyBenson S. Chen; Erik Holzinger; Magali Taiel; Patrick Yu-Wai-Man2022-09
4 An Exploratory Study to Investigate the Utility of Clinical Screening for Neurodegenerative Disease in Age-Related Eye Disease ResearchVictoria S. Pelak; Yosbelkys Martin Paez; Jennifer L. Patnaik; Samantha K. Holden; Prem S. Subramanian; Marc T. Mathias; Naresh Mandava; Anne M. Lynch2022-09
5 Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi ApproachRaymond S. Douglas; Andrea L. Kossler; Jody Abrams; Cesar A. Briceño; David Gay; Andrew Harrison; Michael Lee; John Nguyen; Shannon S. Joseph; Dianne Schlachter; Jeremy Tan; Judah Lynch; Louisa Oliver; Richard Perry; Shoaib Ugradar2022-09
6 Impact of Greater Occipital Nerve Block on Photophobia Levels in Migraine PatientsJavier A Membrilla; Íñigo de Lorenzo; Lucía Sánchez-Casado; María Sastre; Javier Díaz de Terán2022-09
7 Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE StudyValérie Biousse; Nancy J Newman; Patrick Yu-Wai-Man; Valerio Carelli; Mark L Moster; Catherine Vignal-Clermont; Thomas Klopstock; Alfredo A Sadun; Robert C Sergott; Rabih Hage; Simona Esposti; Chiara La Morgia; Claudia Priglinger; Rustum Karanja; Laure Blouin; Magali Taiel; José-Alain Sahel; LHON ...2021-09
8 Acute Care and Treatment of MigraineSpingos Konstantinos, MD, PgD; Michail Vikelis, MD, MSc, PhD; Alan Rapoport, MD2020-12
9 Gabapentin and Memantine for Treatment of Acquired Pendular Nystagmus: Effects on Visual OutcomesElodie Nerrant; Lucie Abouaf; Frédéric Pollet-Villard; Anne-Laure Vie; Sandra Vukusic; Julien Berthiller; Bettina Colombet; Alain Vighetto; Caroline Tilikete2020-06
10 Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of OpicinumabJennifer Petrillo; Laura Balcer; Steven Galetta; Yi Chai; Lei Xu; Diego Cadavid2019-06
11 Neurological and Ophthalmological Manifestations of Varicella Zoster VirusSachin Kedar; Lakshman N. Jayagopal; Joseph R. Berger2019-06
12 Evaluation of Vision-Related Quality of Life in Chinese Patients With Leber Hereditary Optic Neuropathy and the G11778A Mutation.Shilei Cui; MD; Hanqiu Jiang; MD; PhD; Jingting Peng; MD; PhD;Jiawei Wang; MD; PhD; Xiaojun Zhang; MD; PhD2019-03
13 Rehabilitation of Visual Loss: Where We Are and Where We Need to BeBehzad Mansouri, MD, PhD, FRCPC; Marinya Roznik, Bsc; Joseph F. Rizzo III, MD; Sashank Prasad, MD2018-06
14 More Than Meets the Eye: The Eye and Migraine -- What You Need to KnowKathleen B. Digre, MD2018-06
15 Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment TrialMartin W. ten Hove, MD; Deborah I. Friedman, MD; Anil D. Patel, MD; Isabella Irrcher, PhD; Michael Wall, MD; Michael P. McDermott, PhD; for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
16 Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E. Cello, BS; John L. Keltner, MD; Chris A. Johnson, PhD; Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
17 Correlation of Visual Quality of Life With Clinical and Visual Status in Friedreich Ataxia
1 - 25 of 17